What do we know about palmoplantar pustulosis? - Wikidata - wikimedia - TriplyDB

What do we know about palmoplantar pustulosis?

What do we know about palmoplantar pustulosis?

http://www.wikidata.org/entity/Q38926801

about

Hepatitis due to EBV-reactivation under infliximab in a psoriasis patient.Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management.

P2860

Q48296471-40DDC24C-3E29-4351-9974-5A8B7C7109A3 Q55152453-01D24CC3-21ED-4972-9ADF-B9E6FDC138E0

P2860

What do we know about palmoplantar pustulosis?

http://www.wikidata.org/entity/Q38926801

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

What do we know about palmoplantar pustulosis?

@en

type

label

What do we know about palmoplantar pustulosis?

@en

prefLabel

What do we know about palmoplantar pustulosis?

@en

P1433

Q38926801-9FD6E3DC-08E4-40C7-A7E1-561062211901

P1476

Q38926801-CD7CD7D6-FA86-41C0-9282-B54A6DDAE4B9

P2093

Q38926801-89C6B6A4-3931-4A38-882E-FF094BDF5898

Q38926801-976917BD-77E8-4DEB-8BA3-F26C75CBFE6E

Q38926801-CA7B4419-2EC5-4D3B-85F0-A11F1C9BEC20

P2860

Q38926801-025CE9D4-EA32-4BB9-8938-7550C62F6874

Q38926801-06059A72-38B4-481F-B77C-669935D3A2F0

Q38926801-0ACAB5B4-4AF9-44F3-9AB7-DF56A19BA112

Q38926801-14EA8DF4-E7D1-4ED9-804C-BE961AEB24A3

Q38926801-16D096D6-FD2B-4068-8266-742B9CAFCA62

Q38926801-36E539C4-5072-4B5F-A61A-1C71DFD429E8

Q38926801-42AC296F-85EE-4359-9294-FB2D93F99B71

Q38926801-4C6561B0-BFC6-4A9A-95BB-A7E7F4BDC202

Q38926801-4E4E11E1-8A7D-4854-9626-090450D3E24B

Q38926801-58D7823C-0DD8-4816-BBB8-3EDFE8E81001

P304

Q38926801-18805581-8EC0-481D-85A6-D8F5DF61C72E

P31

Q38926801-FF03A920-0E20-4604-92BE-E7BFB1F25A43

P356

Q38926801-EB29B236-08DA-42F2-84DF-53E7C5EB258C

P433

Q38926801-6C3D8F4D-30C1-4A86-BFAF-21C059DBFDE3

P478

Q38926801-6C5882BF-3AD4-4D2A-9A05-3CD95A9F69BF

P577

Q38926801-9CDDA2F7-4AA1-438E-AE9D-4B2C6669A641

P698

Q38926801-829A9C4D-8C5F-40FC-9D02-AE0EF31F4D93

P356

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

What do we know about palmoplantar pustulosis?

@en

P2093

H Wolska

http://www.w3.org/2001/XMLSchema#string

L Rudnicka

http://www.w3.org/2001/XMLSchema#string

M Misiak-Galazka

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.

Retrospective analysis of the treatment of psoriasis of the palms and soles.

Clinical features of 53 cases with pustulotic arthro-osteitis

Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.

Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion.

Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.

Hydroxyurea therapy.

Extra-palmoplantar lesions associated with palmoplantar pustulosis.

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.

P304

38-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDV.13846

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27521275

http://www.w3.org/2001/XMLSchema#string